Controversial testing guidance 'absolutely came from the CDC,' task force official says
A controversial guideline posted by the U.S. Centers for Disease Control and Prevention last month about who should be tested for COVID-19 was approved by the agency's director, Dr. Robert Redfield, according to Adm. Brett Giroir, assistant secretary for health at the U.S. Department of Health and Human Services.
"It absolutely came from the CDC," Giroir, a key member of the White House Coronavirus Task Force who is in charge of coordinating the government's testing efforts, told ABC News' Cecilia Vega in an interview Friday on "Good Morning America."
The guideline in question said it wasn't necessary to test people without COVID-19 symptoms, even if they had been exposed to the virus.
"There are thousands of people at the CDC. I have no idea who The New York Times talked to, but I know for a fact that the version that went to the task force was reviewed and approved by Dr. Redfield," Giroir continued. "It was reviewed and approved by the senior scientist who was the incident manager and in multiple emails to me said that the pertinent issues were reviewed by subject matter experts."
Giroir was referring to a recent article by The New York Times that reported the guideline was not written by CDC scientists and was posted to the agency's website despite their serious objections. The article cited several people familiar with the matter as well as internal documents obtained by the newspaper.
During the interview on "GMA," Giroir disputed that the guideline recommended against testing those who are asymptomatic and said more clarification would be released soon.
"In fact, there were specific recommendations to test asymptomatic (individuals) in outbreak areas," he noted. "What they said was, if you're asymptomatic after exposure, you should do it within the context of public health or medical advice." he noted.
"I want people to know that if you are asymptomatic you can still spread the virus and we want them to be tested," he added.
Giroir, who is also a medical doctor, said politics is not part of the decision-making that is happening on the coronavirus task force and that it is a "science-based, evidence-based process ... with the scientists leading."
He agreed with Redfield's recent statement on Capitol Hill that a potential COVID-19 vaccine won't be widely available until the middle of next year.
"But the point that I want to emphasize is, we could immunize 5% or 10% of the population and get 90% of the benefit by ring-fencing the vulnerable, like in nursing homes or vaccinating our teachers or those who have hypertensions," Giroir said. "If we had a vaccine, even a few million in November, it could make an enormous impact on the health of the country. But it is also true that everyone who wants a vaccine may not be able to get it till mid-next year."
ABC News' Kelly McCarthy contributed to this report.